Evidence map›Paper›PMID 32877922›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2020

Frailty Is Associated With Neutrophil Dysfunction Which Is Correctable With Phosphoinositol-3-Kinase Inhibitors.

Daisy Wilson, William Drew, Alice Jasper, Helena Crisford, Peter Nightingale, Paul Newby, Thomas Jackson, Janet M Lord, Elizabeth Sapey

Open access · hybridAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Senotherapy for chronic lung disease.Pharmacological reviews · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  13. Article
  14. The persistent inflammation in COPD: is autoimmunity the core mechanism?European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Daisy WilsonMRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital Birmingham, UK.
William DrewBirmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital Birmingham, UK.
Alice JasperBirmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital Birmingham, UK.
Helena CrisfordBirmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital Birmingham, UK.
Peter NightingaleNIHR Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, UK.
Paul NewbyBirmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital Birmingham, UK.
Thomas JacksonMRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital Birmingham, UK.
Janet M LordMRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital Birmingham, UK.
Elizabeth SapeyBirmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital Birmingham, UK.
Queen Elizabeth Hospital Birmingham · GBUniversity Hospitals Birmingham NHS Foundation Trust · GB

Funding

Department of HealthMedical Research Council MR/K00414X/1Medical Research Council MR/L008335/1Medical Research Council MR/P021220/1Versus Arthritis
6 · The paper itself

Abstract

Neutrophil dysfunction has been described with age, appears exaggerated in infection, with altered phosphoinositol signaling a potential mechanism. However, functional aging is heterogeneous. Frailty is a negative health status and is more common in older adults. We hypothesized that neutrophil migration may be compromised in frailty, associated with the degree of frailty experienced by the older person. We compared measures of frailty, neutrophil function, and systemic inflammation in 40 young and 77 older community-dwelling adults in the United Kingdom. Systemic neutrophils exhibited an age-associated reduction in the accuracy of migration (chemotaxis) which was further blunted with frailty. The degree of migratory inaccuracy correlated with physical (adjusted hand grip strength) and cognitive (Stroop test) markers of frailty. Regression analysis demonstrated that age, Charlson comorbidity index, and frailty index were able to predict neutrophil chemotaxis. Reduced chemotaxis of neutrophils from frail adults could be reversed using selective PI3K inhibitors. Exposure of neutrophils from young adults to plasma from chronically inflamed frail older adults could not recapitulate the migratory deficit in vitro, and there were no relationships with systemic inflammation and neutrophil dysfunction. Frailty exaggerated the neutrophil deficits seen with advanced age but aspects of the frailty-associated deficit in neutrophil function are rescuable and thus potentially form a therapeutic target to improve outcomes from infection in older adults.

Indexed as

AdultAgedAged, 80 and overChemotaxisCognition DisordersC-Reactive ProteinCytokinesFemaleFrailtyGeriatric AssessmentHand StrengthHumansIndependent LivingLeukocyte ElastaseMaleMiddle AgedC-Reactive ProteinCytokinesLeukocyte ElastasePhosphoinositide-3 Kinase InhibitorsComorbidityInflammationInnate immunityProteinases

Identifiers

PMID32877922
PMCPMC7662170
OpenAlexW3082915413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.